Board of Directors
Roy Williams III
Roy is a 5 year lung cancer survivor, who has had a 45 year career in the wholesale/retail, real estate and healthcare industries. He and his wife Mary have six children and four grandchildren.
Bob has been employed in the railroad industry on the supply side in various sales and marketing capacities for over 40 years. He is a native St. Louisan along with his wife Beth, and two daughters, two grandchildren and one expected in October. In September 2012 his wife, Beth, was diagnosed with stage 4 metastatic lung cancer. She passed away in September 2013. Since that time Bob became involved with LCC and directs most of his efforts toward fundraising activities.
Dr. Shah is a board-certified pulmonologist with board certifications in critical care medicine and internal medicine. He has been in practice for 6 years at St. Luke’s Hospital. He is the Director of Pulmonary and Critical Care Medicine. He completed his training at Northwestern Memorial Hospital in Chicago but is a native of St. Louis.
Dr. Bobby Shah
Gary Gianino is AVP, Business Banking, with Enterprise Bank & Trust. He focuses on providing customized banking solutions for privately held, small- and medium-sized businesses.. With over 30 years of business experience, he has a broad and diverse background, and has held a variety of leadership roles in business development and operations. Prior to joining Enterprise Bank & Trust, he worked for not-for-profit, for profit and joint venture companies in the health care, risk management, and aerospace & defense industries.
He is active in his community, and serves as an Advisory Director on the Nazareth Living Center Foundation Board, and volunteers with Variety the Children’s Charity of St. Louis. He has also held a number of positions on the Board of Trustees of Nazareth Living Center, the Board of Managers for the South County YMCA, and the Board of Directors of the America-Israel Chamber of Commerce of St. Louis.
Maria Quintos Baggstrom MD FACP is board certified in Medical Oncology and Internal Medicine. Dr. Baggstrom is an associate professor of medicine at Washington University in St. Louis and specializes in solid tumors originating from the lung and thorax. Her research/clinical interests are in clinical trial methodology and clinical trials of therapeutic agents in lung cancer. She graduated from medical school at the University of Texas at Houston. She completed her Internal Medicine residency and her Hematology and Medical Oncology fellowship at the University of North Carolina at Chapel Hill. She joined Washington University in 2005.
Dr. Maria Baggstromm
As a graduate of the Missouri University of Science and Technology with a degree in Geological Engineering, a Certified General Contractor and a licensed Professional Engineer in four states (including Missouri and Illinois), Cherie brings credentials and skills rarely seen in the radon mitigation industry. Cherie is certified by the National Radon Proficiency Program (NRPP/AARST), a member of the American Association of Radon Scientists and Technicians (AARST) and currently serves as the Vice President of the Heartland Chapter of AARST. Cherie is also a certified radon measurement and mitigation technician in Illinois under the Illinois Emergency Management Association (IEMA).
Cherie Summa, P.E.
Bio Coming Soon
Ramaswamy Govindan, MD, is the Anheuser Busch Chair of Medical Oncology and Professor of Medicine in the Department of Medicine at Washington University School of Medicine (WUSM). Dr. Govindan received his medical degree from the University of Madras in India, and undertook internship and residency training in internal medicine at Michael Reese Hospital and Medical Center in Chicago. He completed his fellowship in hematology-oncology at WUSM and joined the faculty in 1998. He is interested in studying genomic alterations in lung cancer and translating these findings in the clinic. He has led several national and international clinical trials in lung cancer. He is the Principal Investigator for the NCI sponsored ALCHEMIST Trial to study the impact of targeted therapy in early stage lung cancer. He is the co-chair of the lung cancer working group for The Cancer Genome Atlas (TCGA) project and the Cancer Driver Discovery Project (CDDP) funded by the National Cancer Institute (NCI) He is also the Principal Investigator of the NCI sponsored Paul Calabresi K12 Oncology Training Program and the R25 STRENGTH program at WUSM both funded by the NCI.